Cefiderocol to treat complicated urinary tract infection.
Matthew William McCarthy
págs. 177-184
Darolutamide for treatment of castration-resistant prostate cancer.
Logan P. Rhea, S. Mendez Marti, Jeanny B. Aragon Ching
págs. 185-193
Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera.
Sandro M. Wagner, Thomas Melchardt, Richard F. Greil
págs. 195-202
Tenapanor for constipation-predominant irritable bowel syndrome.
S. Siddiqui, Brooks D. Cash
págs. 203-210
MicroRNAs and microbiota: Is there a cross talk?
Malak Rizk, Şükrü Tüzmen
págs. 211-226
New product intros [cefiderocol, imipenem/cilastatin sodium/relebactam (new combination), tazemetostat (first-in-class)].
págs. 227-228
© 2001-2025 Fundación Dialnet · Todos los derechos reservados
Coordinado por: